# Allergan clinical trials: 505 on ClinicalTrials.gov (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 505 trials with Allergan as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Allergan: 505 rows for $25.25, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/allergan

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 505
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 505, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| July 11, 2022 | NCT05452070 | A Study to Assess Adverse Events and Change in Disease Activity of HArmonyCa Lidocaine Injectable Gel for Mid Face Soft Tissue Augmentation... | Allergan | Phase 3 | Completed | Mid Face Volume Deficit | 171 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05452070) |
| May 26, 2022 | NCT05393089 | Study of AGN-190584 Eye Drops to Assess Safety and Efficacy in Participants Aged 40-80 Years With Pseudophakic Presbyopia | Allergan | Phase 2 | Withdrawn | Presbyopia | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05393089) |
| December 10, 2021 | NCT05152576 | A Study To Assess the Adverse Effects and Change in Condition of OnabotulinumtoxinA X Injection in Adult Participants With Forehead Lines | Allergan | Phase 2 | Completed | Forehead Lines | 124 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05152576) |
| November 15, 2021 | NCT05119777 | HArmonyCa Injectable Gel for Mid Face Soft Tissue Augmentation | Allergan | Phase 4 | Completed | Soft Tissue Augmentation | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05119777) |
| October 29, 2021 | NCT05100199 | A Study to the Assess the Change in Condition and Adverse Events of OnabotulinumtoxinA X Injection in Adult Participants With Glabellar... | Allergan | Phase 2 | Completed | Glabellar Lines | 328 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05100199) |
| October 22, 2021 | NCT05088980 | Study to Assess Effectiveness and Adverse Events of JUVEDERM VOLBELLA With Lidocaine Injection in Correcting Infraorbital Hollowing in... | Allergan | Phase 3 | Completed | Infraorbital Hollowing | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05088980) |
| October 14, 2021 | NCT05077488 | VFORM: Prospective, Open Label, Study to Evaluate VOLIFT With Lidocaine Treatment for FORehead Contouring and Marionette Lines | Allergan | Phase 4 | Completed | Marionette Lines Forehead Contouring | 163 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05077488) |
| August 19, 2021 | NCT05013424 | A Study of OnabotulinumtoxinA X Injection in Adult Participants With Glabellar Lines | Allergan | Phase 2 | Completed | Glabellar Lines | 92 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05013424) |
| July 30, 2021 | NCT04983589 | A Study to Assess Safety and Efficacy in Participants Age 40 to 55 With Presbyopia (Old Eye) Who Receive AGN-190584 in Both Eyes Twice Daily | Allergan | Phase 3 | Completed | Presbyopia | 230 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04983589) |
| May 24, 2021 | NCT04897867 | CoolSculpting® Elite for Non-Invasive Fat Reduction | Allergan | Phase 4 | Completed | Non-invasive Fat Reduction | 110 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04897867) |
| May 18, 2021 | NCT04891419 | JUVÉDERM® VOLUMA® With Lidocaine for Correction of Temple Hollowing in Chinese Population | Allergan | Phase 3 | Completed | Temple Hollowing | 168 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04891419) |
| April 2, 2021 | NCT04829747 | Study to Assess Adverse Events (AEs) When Oral Atogepant Tablet is Given to Adult Chinese Participants Who Completed Study 3101-303-002 to... | Allergan | Phase 3 | Completed | Chronic Migraine | 3 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04829747) |
| February 5, 2021 | NCT04740827 | Atogepant for Prophylaxis of Migraine in Participants Who Failed Previous Oral Prophylactic Treatments. | Allergan | Phase 3 | Completed | Episodic Migraine | 315 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04740827) |
| December 29, 2020 | NCT04687046 | A Study of JUVÉDERM VOLUX® Injectable Gel for Chin Enhancement in Chinese Adults Using Real-World Evidence | Allergan | Observational | Completed | Chin Retrusion | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04687046) |
| December 7, 2020 | NCT04655300 | Evaluation of Age-related Skin Changes Using Clinical Probe Measurements and Imaging Modalities in Chinese Subjects | Allergan | Observational | Completed | Age-related Skin Changes | 102 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04655300) |
| November 30, 2020 | NCT04647214 | 18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA) | Allergan | Observational | Completed | Open-angle Glaucoma, Ocular Hypertension | 220 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04647214) |
| November 17, 2020 | NCT04631588 | Intradermal (ID) BOTOX in the Treatment of Facial Fine Lines | Allergan | Phase 1 | Completed | Facial Fine Lines | 172 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04631588) |
| October 30, 2020 | NCT04609020 | Study to Evaluate Subject Satisfaction With Facial Appearance and Impact of Combined Facial Treatment | Allergan | Phase 4 | Completed | Facial Rhytides, Skin Folds, Loss of Volume and Skin Quality | 64 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04609020) |
| September 28, 2020 | NCT04567589 | A Study to Evaluate Awareness and Knowledge of the Fibristal Additional Risk Minimization Measures Among Healthcare Professionals in Canada | Allergan | Observational | Withdrawn | Uterine Fibroids | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04567589) |
| September 28, 2020 | NCT04567095 | A Study to Evaluate Awareness and Knowledge of the Fibristal Additional Risk Minimization Measures Among Patients in Canada | Allergan | Observational | Withdrawn | Uterine Fibroids | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04567095) |
| September 23, 2020 | NCT04559984 | JUVÉDERM VOLUX® for Chin Retrusion in China | Allergan | Phase 3 | Completed | Chin Retrusion | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04559984) |
| September 17, 2020 | NCT04552249 | Evaluation of Age-related Skin Changes and Instrument Reliability Using Clinical Probe Measurements and Imaging Modalities | Allergan | Observational | Completed | Age-related Skin Changes | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04552249) |
| June 4, 2020 | NCT04414397 | A Study Evaluating JUVÉDERM® VOLUMA® XC Injectable Gel for Correction of Temple Hollowing in Adult Participants ≥ 22 Years Old | Allergan | Phase 3 | Completed | Temple Hollowing | 205 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04414397) |
| May 19, 2020 | NCT04393441 | Efficacy and Safety of a New Artificial Tear Formulation Compared With Systane Ultra Multidose in Participants With Dry Eye Disease | Allergan | Phase 3 | Completed | Dry Eye Disease (DED) | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04393441) |
| May 15, 2020 | NCT04390581 | A Study to Evaluate the Effect of Juvederm Volift With Lidocaine on Aging Hands in Participants Age 35 and Older | Allergan | Phase 4 | Completed | Skin Depressions, Skin Elasticity, Skin Laxity | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04390581) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 31 |
| Phase 1/2 | 8 |
| Phase 2 | 89 |
| Phase 2/3 | 6 |
| Phase 3 | 124 |
| Phase 4 | 97 |
| Not applicable | 42 |
| Observational | 108 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 447 |
| Terminated | 45 |
| Withdrawn | 12 |
| Active not recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Ocular Hypertension | 74 |
| Glaucoma, Open-Angle | 48 |
| Dry Eye Syndromes | 42 |
| Glaucoma | 33 |
| Migraine Disorders | 25 |
| Urinary Bladder, Overactive | 24 |
| Macular Edema | 22 |
| Muscle Spasticity | 17 |
| Retinal Vein Occlusion | 16 |
| Macular Degeneration | 15 |
| Urinary Incontinence | 14 |
| Acne Vulgaris | 11 |
| Torticollis | 9 |
| Conjunctivitis, Allergic | 9 |
| Stroke | 7 |
| Rosacea | 7 |
| Erythema | 7 |
| Alopecia | 7 |
| Presbyopia | 7 |
| Cystitis, Interstitial | 7 |
| Diabetes Mellitus | 6 |
| Asthma | 6 |
| Gastroparesis | 6 |
| Leiomyoma | 5 |
| Hyperhidrosis | 5 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Polish restaurants in the United States](https://specstream.ai/data/businesses/polish-restaurants/united-states)
- [Puerto Rican restaurants in the United States](https://specstream.ai/data/businesses/puerto-rican-restaurants/united-states)
- [Scientific laboratories in the United States](https://specstream.ai/data/businesses/scientific-laboratories/united-states)
- [Spine surgery practices in the United States](https://specstream.ai/data/businesses/spine-surgery-practices/united-states)
- [Textile mills in the United States](https://specstream.ai/data/businesses/textile-mills/united-states)
- [Vascular medicine practices in the United States](https://specstream.ai/data/businesses/vascular-medicine-practices/united-states)
